CEO/Managing Director
Tryptamine Therapeutics
Tryp is focused on identifying and developing clinical-stage compounds specifically for orphan diseases and conditions with significant unmet medical needs. The company aims to enhance treatment options for patients suffering from these rare and challenging health issues.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$4.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Tryp is focused on identifying and developing clinical-stage compounds specifically for orphan diseases and conditions with significant unmet medical needs. The company aims to enhance treatment options for patients suffering from these rare and challenging health issues.